Nvidia Earnings Could Be a Key Test for US Equities Amid Geopolitical Tensions After Xi Summit UK Regulator Ofcom Says TikTok and YouTube Not Safe Enough for Children Scott Bessent Anticipates Substantial Disinflation as Kevin Warsh Takes the Helm at the Federal Reserve National Motorsport Community Mourns Loss of NASCAR Champion Kyle Busch at Age 41 Consumer Sentiment Falls to Historic Low in May as Iran Conflict Fuels Inflation Concerns HELOC and Home Equity Loan Rates May 24 2026 Truist Named Best Lender Amidst Competitive Rates MCRB Q1 2026 Earnings EPS Misses Estimates Revenue Not Reported Stock Declines Diamond Hill Investment Group Q1 2025 Earnings Steady EPS Amid Quiet Market Response Fossil Group FOSL Q1 2026 Earnings EPS Beat on Lower Loss Amid Continued Market Challenges Post Holdings Q1 2026 Earnings Strong EPS Beat Masks Mixed Underlying Performance CervoMed Inc CRVO Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Decline FNGR Q4 2024 Earnings EPS Misses Estimates as Company Navigates Transition Camping World Holdings CWH Edges Higher as Stock Tests Key Resistance Levels Oatly Group OTLY Slides 177 as Shares Test Key Support Levels Nabors Industries NBR Falls 44 as Oil Service Shares Face Renewed Pressure NNN REIT Inc NNN Holds Steady Near Support Awaiting Catalyst Acumen Pharmaceuticals ABOS Holds Ground Near Resistance Can Biotech Momentum Continue Silver Mean Reversion Setup Points to Potential Rally Toward 7982 as Hyperbolic Phase Emerges CALY Q1 2026 Earnings EPS Surges 288 Above Estimates Stock Dips 315 Kyivstar Group Warrant Shows Modest Decline Holds Above Key Support KREF Stock Surges Over 1 Real Estate Finance Trust Testing Key Resistance at 699 John Hancock Premium Dividend Fund PDT Edges Higher as YieldSeekers Take Notice A Paradise Acquisition Corp Unit APADU Holds Steady at 1000 Amid Neutral Trading Satellogic Warrants SATLW Plunge 11 Key Support Levels in Focus Dave Busters Shares Surge Over 6 as Stock Bounces from Support PLAY Inhibikase Therapeutics IKT Holds Steady at 170 as Support and Resistance Levels Tighten Citius Pharmaceuticals CTXR Drops 464 as Weakness Tests Support at 063